yeah, makes one think best to stay away from bio and come back when the wind changes or big individual stock specific catalysts are approaching. Looking at neu, no matter how good the company appears be doing from a fundamental perspective, getting a rising shareprice seems like an up hill battle and no big near term catalysts are near sufficient to cause a character change in shareprice behaviour imo.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.05%
!
$12.99

Share Price, page-15588
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.99 |
Change
0.135(1.05%) |
Mkt cap ! $1.617B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.85 | $6.981M | 533.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 891 | $12.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.99 | 366 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 501 | 12.980 |
6 | 719 | 12.970 |
9 | 1952 | 12.960 |
5 | 1289 | 12.950 |
5 | 1596 | 12.940 |
Price($) | Vol. | No. |
---|---|---|
13.000 | 880 | 5 |
13.010 | 1337 | 11 |
13.020 | 1262 | 6 |
13.030 | 1977 | 11 |
13.040 | 1415 | 4 |
Last trade - 15.52pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online